Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Imidazole Phenoxyacetic Acids as Inhibitors of USP30 for Neuroprotection Implication via the Ubiquitin-Rho-110 Fluorometric Assay: Design, Synthesis, and In Silico and Biochemical Assays
Subhankar P. Mandal, B. R. Prashantha Kumar, Md Tanjim Alam, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 9, pp. 1433-1445
Closed Access | Times Cited: 14

Showing 14 citing articles:

Anticancer potential of novel symmetrical and asymmetrical dihydropyridines against breast cancer via EGFR inhibition: molecular design, synthesis, analysis and screening
Syed Faizan, Sirajunisa Talath, Adil Farooq Wali, et al.
RSC Advances (2024) Vol. 14, Iss. 16, pp. 11368-11387
Open Access | Times Cited: 5
Mitophagy in Neurodegenerative Diseases: Mechanisms of Action and the Advances of Drug Discovery
Panpan Yang, Shuai Wen, Xin Wang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Endogenous opiates and behavior: 2022
Richard J. Bodnar
Peptides (2023) Vol. 169, pp. 171095-171095
Closed Access | Times Cited: 12
Structural Dynamics of the Ubiquitin Specific Protease USP30 in Complex with a Cyanopyrrolidine-Containing Covalent Inhibitor
Darragh P. O’Brien, Hannah B. L. Jones, Yuqi Shi, et al.
Journal of Proteome Research (2025) Vol. 24, Iss. 2, pp. 479-490
Open Access
Role of Deubiquitinases in Parkinson’s Disease—Therapeutic Perspectives
Pernille Y. Ø. Nielsen, Justyna Okarmus, Morten Meyer
Cells (2023) Vol. 12, Iss. 4, pp. 651-651
Open Access | Times Cited: 9
Novel hybrids of 1,2,3-triazole-benzoxazole: design, synthesis, and assessment of DprE1 enzyme inhibitors using fluorometric assay and computational analysis
Manisha Singh, Sarah M. Batt, Christian S. Carnero Canales, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 2
New LPA1 receptor modulators: Design, synthesis, in-silico, and anticancer studies of triazole and oxadiazole analogs
Meduri Bhagyalalitha, S R Pavan, Ashwini Prabhu, et al.
Journal of Molecular Structure (2023) Vol. 1295, pp. 136672-136672
Closed Access | Times Cited: 5
Repurposing the inhibitors of MMP-9 and SGLT-2 against ubiquitin specific protease 30 in Parkinson’s disease: computational modelling studies
Mohammed M. Alshehri, Ammar Usman Danazumi, Mohammed Kanan Alshammari, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 3, pp. 1307-1318
Closed Access | Times Cited: 4
Targeted to neuronal organelles for CNS drug development
Zheng Ying, Na Ye, Qilian Ma, et al.
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 115025-115025
Closed Access | Times Cited: 4
Structural Dynamics of the Ubiquitin Specific Protease USP30 in Complex with a Cyanopyrrolidine-Containing Covalent Inhibitor
Darragh P. O’Brien, Hannah B. L. Jones, Yuqi Shi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 1
Molecular dynamics articulated multilevel virtual screening protocol to discover novel dual PPAR α/γ agonists for anti-diabetic and metabolic applications
Subhankar P. Mandal, Syed Faizan, Nulgumnalli Manjunathaiah Raghavendra, et al.
Molecular Diversity (2022) Vol. 27, Iss. 6, pp. 2605-2631
Closed Access | Times Cited: 6
Targeting Deubiquitinating Enzymes (DUBs) That Regulate Mitophagy via Direct or Indirect Interaction with Parkin
Eliona Tsefou, Robin Ketteler
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12105-12105
Open Access | Times Cited: 3
Design, synthesis and evaluation of new thiazolidin-4-ones as LPA 1 receptor antagonists for breast cancer therapy
Meduri Bhagyalalitha, Pavan SR, Ashwini Prabhu, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 8, pp. 769-790
Open Access
Therapeutic potential of Parkin and its regulation in Parkinson’s disease
Narukkottil Safreena, Indu R. Nair, Goutam Chandra
Biochemical Pharmacology (2024) Vol. 230, pp. 116600-116600
Closed Access
Page 1

Scroll to top